1
|
Roy R, Vinjamuri S, Baskara Salian R, Hafeez N, Meenashi Sundaram D, Patel T, Gudi TR, Vasavada AM. Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review. Cureus 2023; 15:e42113. [PMID: 37602002 PMCID: PMC10436676 DOI: 10.7759/cureus.42113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/19/2023] [Indexed: 08/22/2023] Open
Abstract
Heart failure remains a leading cause of hospitalization and death, and presents a significant challenge for healthcare providers despite the advancements in its management. This umbrella review aimed to pool the results of meta-analyses on the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in the treatment of heart failure patients. A literature search was done on five databases: PubMed, Cochrane Library, Scopus, Global Index Medicus, and Science Direct for articles with full texts available online. Meta-analyses of five or more randomized controlled trials (RCTs) were included; the assessment of multiple systematic reviews (AMSTAR) was used to assess the quality of included studies. A systematic search identified 10 relevant meta-analyses of RCTs, with primary analyses including outcome data from 171,556 heart failure patients. A pooled review showed that SGLT-2 inhibitors significantly reduced the risk of heart failure hospitalization, cardiovascular death, mortality, serious adverse events, and improved quality of life. SGLT-2 inhibitors are likely safe and effective in managing patients with heart failure especially considering the acute outcomes.
Collapse
Affiliation(s)
- Raj Roy
- Internal Medicine, Gandhi Medical College and Hospital, Secunderabad, IND
| | - Saketh Vinjamuri
- Internal Medicine, Gandhi Medical College and Hospital, Secunderabad, IND
| | | | | | - Dakshin Meenashi Sundaram
- Internal Medicine, Employees State Insurance Corporation (ESIC) Medical College and Post Graduate Institute of Medical Sciences and Research (PGIMSR), Chennai, IND
| | - Tirath Patel
- Surgery, American University of Antigua, St. John, ATG
| | | | | |
Collapse
|
2
|
Mahfooz K, Vasavada AM, Joshi A, Pichuthirumalai S, Andani R, Rajotia A, Hans A, Mandalia B, Dayama N, Younas Z, Hafeez N, Bheemisetty N, Patel Y, Tumkur Ranganathan H, Sodala A. Waterpipe Use and Its Cardiovascular Effects: A Systematic Review and Meta-Analysis of Case-Control, Cross-Sectional, and Non-Randomized Studies. Cureus 2023; 15:e34802. [PMID: 36915837 PMCID: PMC10008028 DOI: 10.7759/cureus.34802] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2022] [Accepted: 02/09/2023] [Indexed: 02/11/2023] Open
Abstract
Approximately 100 million people globally smoke cigarettes, making it a significant and quickly spreading global tobacco epidemic. Substance use disorders are frequently evaluated by non-randomized studies. Tobacco use and its impacts on the cardiovascular system were the subjects of a comprehensive search across five electronic databases: Cochrane, MEDLINE, Scopus, Embase, and PubMed. The findings demonstrated that waterpipe smokers in comparison to non-smokers have immediate elevations in heart rate and blood pressure, lower levels of high-density lipoprotein, higher levels of low-density lipoprotein, higher levels of triglycerides, higher levels of fasting blood glucose, and a higher heart rate. Users of waterpipes and cigarettes had similar average heart rates, blood pressure, and lipid levels, with the exception that waterpipe smokers had greater total cholesterol. Smoking a waterpipe has significant negative effects on the cardiovascular system comparable to cigarette smoking, and non-randomized studies proved to yield substantial evidence related to its cardiovascular effects. Such study designs can be used to evaluate substance use and its cardiovascular impact.
Collapse
Affiliation(s)
- Kamran Mahfooz
- Internal Medicine, Lincoln Medical Center, New York, USA
| | - Advait M Vasavada
- Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.,Medicine, Shri M. P. Shah Government Medical College, Jamnagar, IND
| | - Arpit Joshi
- Medicine, B. J. (Byramjee Jeejeebhoy) Medical, Ahmedabad, IND
| | | | - Rupesh Andani
- Internal Medicine, Jeevandhara Hospital, Jamnagar, IND
| | | | - Aakash Hans
- Internal Medicine, Henry Ford Health System, Detroit, USA
| | - Bilvesh Mandalia
- House Officer, Lokmanya Tilak Municipal General Hospital and Medical College, Sion Mumbai, Mumbai, IND
| | - Neeraj Dayama
- Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, USA
| | - Zara Younas
- Medicine, King Edward Medical University, Lahore, PAK
| | | | - Niharika Bheemisetty
- Pediatrics, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA
| | - Yash Patel
- Medicine, Gujarat Cancer Society Medical College, Ahmedabad, IND
| | | | - Ashok Sodala
- Medicine, Shri M. P. Shah Government Medical College, Jamnagar, IND
| |
Collapse
|
4
|
Khan F, Sarmad SF, Abbas F, Hafeez N, Wasim E, Kumari U, Jabbar AA. Breast Cancer Screening: Transgender Discrimination and Marginalization From Pakistan Perspective. Acad Radiol 2022; 30:779. [PMID: 35750608 DOI: 10.1016/j.acra.2022.05.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Revised: 05/25/2022] [Accepted: 05/26/2022] [Indexed: 11/28/2022]
Affiliation(s)
- Faheemullah Khan
- Department of Radiology (F.K.), Aga Khan University Hospital, Karachi, Sindh ,Pakistan; Department of Medicine (S.F.S.), Jinnah Postgraduate Medical Center, Karachi, Sindh, Pakistan; Department of Medicine (F.A., N.H., E.W.), Mayo Hospital, Lahore, Pakistan; Department of Medicine (U.K.), Dow University of Health Sciences, Karachi, Sindh, Pakistan; Department of Medical Oncology (A.A.J.), Aga Khan University Hospital, Karachi, Sindh, Pakistan
| | - Syed Fozail Sarmad
- Department of Radiology (F.K.), Aga Khan University Hospital, Karachi, Sindh ,Pakistan; Department of Medicine (S.F.S.), Jinnah Postgraduate Medical Center, Karachi, Sindh, Pakistan; Department of Medicine (F.A., N.H., E.W.), Mayo Hospital, Lahore, Pakistan; Department of Medicine (U.K.), Dow University of Health Sciences, Karachi, Sindh, Pakistan; Department of Medical Oncology (A.A.J.), Aga Khan University Hospital, Karachi, Sindh, Pakistan
| | - Fakhar Abbas
- Department of Radiology (F.K.), Aga Khan University Hospital, Karachi, Sindh ,Pakistan; Department of Medicine (S.F.S.), Jinnah Postgraduate Medical Center, Karachi, Sindh, Pakistan; Department of Medicine (F.A., N.H., E.W.), Mayo Hospital, Lahore, Pakistan; Department of Medicine (U.K.), Dow University of Health Sciences, Karachi, Sindh, Pakistan; Department of Medical Oncology (A.A.J.), Aga Khan University Hospital, Karachi, Sindh, Pakistan
| | - Nosheen Hafeez
- Department of Radiology (F.K.), Aga Khan University Hospital, Karachi, Sindh ,Pakistan; Department of Medicine (S.F.S.), Jinnah Postgraduate Medical Center, Karachi, Sindh, Pakistan; Department of Medicine (F.A., N.H., E.W.), Mayo Hospital, Lahore, Pakistan; Department of Medicine (U.K.), Dow University of Health Sciences, Karachi, Sindh, Pakistan; Department of Medical Oncology (A.A.J.), Aga Khan University Hospital, Karachi, Sindh, Pakistan
| | - Ezza Wasim
- Department of Radiology (F.K.), Aga Khan University Hospital, Karachi, Sindh ,Pakistan; Department of Medicine (S.F.S.), Jinnah Postgraduate Medical Center, Karachi, Sindh, Pakistan; Department of Medicine (F.A., N.H., E.W.), Mayo Hospital, Lahore, Pakistan; Department of Medicine (U.K.), Dow University of Health Sciences, Karachi, Sindh, Pakistan; Department of Medical Oncology (A.A.J.), Aga Khan University Hospital, Karachi, Sindh, Pakistan
| | - Usha Kumari
- Department of Radiology (F.K.), Aga Khan University Hospital, Karachi, Sindh ,Pakistan; Department of Medicine (S.F.S.), Jinnah Postgraduate Medical Center, Karachi, Sindh, Pakistan; Department of Medicine (F.A., N.H., E.W.), Mayo Hospital, Lahore, Pakistan; Department of Medicine (U.K.), Dow University of Health Sciences, Karachi, Sindh, Pakistan; Department of Medical Oncology (A.A.J.), Aga Khan University Hospital, Karachi, Sindh, Pakistan.
| | - Adnan Abdul Jabbar
- Department of Radiology (F.K.), Aga Khan University Hospital, Karachi, Sindh ,Pakistan; Department of Medicine (S.F.S.), Jinnah Postgraduate Medical Center, Karachi, Sindh, Pakistan; Department of Medicine (F.A., N.H., E.W.), Mayo Hospital, Lahore, Pakistan; Department of Medicine (U.K.), Dow University of Health Sciences, Karachi, Sindh, Pakistan; Department of Medical Oncology (A.A.J.), Aga Khan University Hospital, Karachi, Sindh, Pakistan
| |
Collapse
|
5
|
Cadzow L, Brenneman J, Sullivan P, Liu H, Shenker S, McGuire M, Grasberger P, Sinkevicius K, Hafeez N, Histen G, Chipumuro E, Hixon J, Krall E, Cogan S, Wilt J, Schlabach M, Stegmeier F, Olaharski A, Wylie A. Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. Eur J Cancer 2020. [DOI: 10.1016/s0959-8049(20)31215-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|